As of 23 September 2026, none of the research peptides searched on the FDA Philippines verification portal is registered, and 7 were not searched. Semaglutide and tirzepatide are registered only as branded prescription medicines (Ozempic, Wegovy, Rybelsus and Mounjaro). A research-grade vial is not a registered medicine.
Legal
Regulatory status by compound
For each compound this site covers: its status with FDA Philippines, the US FDA and the European Medicines Agency, each sourced and dated.
Video transcript
Checking if a medicine is FDA registered, or bringing one into the Philippines? Here are the rules, checked in September 2026. FDA Philippines points you to its verification portal. A registered drug shows a Certificate of Product Registration number and its classification. No certificate means unregistered. Importing or selling an unregistered drug is a prohibited act, and the FDA may seize violative products without a court order. A prescription medicine is dispensed only by a licensed pharmacist, at an FDA-licensed outlet, against a valid prescription, including online orders. Bringing medicines in falls under Joint Circular No. 1 of 2015: passenger baggage, balikbayan boxes and parcels. Prescription drugs: up to the quantity on a prescription with the doctor's PRC licence number. Over-the-counter drugs: 50 grams. Vitamins and supplements: 500 grams in total. Above the limits, without FDA clearance, goods are seized and forfeited, declared or not. Every arriving bag is subject to search. Recent advisories: on 4 September 2026, numbers 2026-1019 and 2026-1020 warned against unregistered tirzepatide vials, and 2026-1013 against a KPV vial. Ozempic, Wegovy, Rybelsus and Mounjaro are registered prescription drugs. Prescribing belongs with a licensed Philippine physician. A research vial is not a registered medicine. Buying from stock already in the Philippines skips customs. Our partner and supplier, Primara Labs, holds stock in Metro Manila. Its vials are for research use only, not approved for human use. Metro Manila orders by noon on a weekday arrive the same day. J&T reaches Luzon in 1 to 2 business days, Visayas 2 to 3, Mindanao 3 to 5. Plus a 60-day money-back guarantee. Read the full rules on Philippines Peptides, then see the catalogue at Primara Labs and order on WhatsApp.
Short answer
Status by compound
| Compound | FDA Philippines | US FDA | EMA |
|---|---|---|---|
| Retatrutide | No registered drug product found on the FDA verification portal | Investigational | No record found |
| Tirzepatide | Registered only as the branded prescription medicine Mounjaro (12 certificates) | Approved for glycemic control in type 2 diabetes mellitus (Mounjaro); weight reduction in obesity or overweight with a comorbidity and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound) | Approved for type 2 diabetes mellitus and weight management (Mounjaro) |
| Semaglutide | Registered only as branded prescription medicines: Ozempic, Wegovy and Rybelsus (17 certificates of product registration) | Approved for glycemic control in type 2 diabetes mellitus and related cardiovascular and kidney risk reduction (Ozempic, Rybelsus); chronic weight management and cardiovascular risk reduction in obesity or overweight (Wegovy) | Approved for type 2 diabetes mellitus (Ozempic, Rybelsus), weight management (Wegovy) and non-cirrhotic MASH with F2 to F3 fibrosis (Kayshild) |
| BPC-157 | No registered drug product found on the FDA verification portal | No record found | No record found |
| TB-500 | No registered drug product found on the FDA verification portal | No record found | No record found |
| GHK-Cu | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| KPV | No registration found; FDA Advisory No. 2026-1013 warns against an unregistered KPV product | No record found | No record found |
| NAD+ | No registration found; FDA Advisory No. 2025-0084 warns against an unregistered NAD product | No record found | No record found |
| MOTS-c | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Elamipretide | Not published: the FDA verification portal was not searched for this name | Approved under accelerated approval for Barth syndrome in patients weighing at least 30 kg | Not published |
| Tesamorelin | No registered drug product found on the FDA verification portal | Approved for reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy | Not approved |
| CJC-1295 | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Ipamorelin | No registered drug product found on the FDA verification portal | No record found | No record found |
| Bremelanotide | Not published: the FDA verification portal was not searched for this name | Approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women | No record found |
| Semax | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Selank | No registered drug product found on the FDA verification portal | No record found | No record found |
| DSIP | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
Sources
US FDA and EMA columns: the regulatory dataset in the Research Desk of Primara Labs, our partner and supplier, which records the Drugs@FDA and EMA source and check date for every cell. FDA Philippines column: this site's search of the FDA verification portal on 23 September 2026, and the registration numbers in the GLP-1 price tracker. Each compound's page repeats its row with the source notes.
The regulation hub
- Are peptides legal in the Philippines?
- How FDA Philippines registration works, and what "not registered" means
- Prescription rules for GLP-1 medicines
- Bringing medicines or peptides into the Philippines
- Is selling peptides legal in the Philippines?
- FDA Philippines advisories on GLP-1s and peptides: timeline
Sources checked 23 September 2026. Primary sources only: statutes, DOH and FDA Philippines issuances, the FDA verification portal and the Bureau of Customs. This is general information, not legal advice.